<DOC>
	<DOCNO>NCT01842347</DOCNO>
	<brief_summary>The purpose study treat child severe , moderate , resistant relapse C. difficile infection determine change intestinal microbiome ( bacteria living intestine ) child receive FMT C. difficile infection . Data collect throughout FMT procedure determine effectiveness help standardize procedure . Stool sample collect look different bacteria intestine FMT .</brief_summary>
	<brief_title>Treatment C. Difficile Infection With Fecal Microbiota Transplantation ( FMT )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Recipient Inclusion Criteria 1 . Older 18 month age 2 . FMT procedure decide treat gastroenterologist base : 1 . Recurrent relapse CDI : Failure standard medical therapy metronidazole , vancomycin fidaxomicin ( age 18 year . Fidaxomicin approve &lt; 18years insurance authorization may possible ) . At least 2 episode CDI require hospitalization 2 . Moderate CDI respond vancomycin least week . 3 . Severe CDI response vancomycin 4 hour . 3 . English speaking Recipient Exclusion Criteria 1 . Lack informed consent/assent . 2 . Not eligible FMT procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>